{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:51:37Z","timestamp":1715993497287},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2011,11,2]],"date-time":"2011-11-02T00:00:00Z","timestamp":1320192000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s11010-011-1141-6","type":"journal-article","created":{"date-parts":[[2011,11,2]],"date-time":"2011-11-02T16:42:12Z","timestamp":1320252132000},"page":"187-194","source":"Crossref","is-referenced-by-count":5,"title":["Chronic mild hyperhomocysteinemia alters ectonucleotidase activities and gene expression of ecto-5\u2032-nucleotidase\/CD73 in rat lymphocytes"],"prefix":"10.1007","volume":"362","author":[{"given":"Emilene B. S.","family":"Scherer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Eduardo B.","family":"Savio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda C.","family":"Vuaden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9a G. K.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maur\u00edcio R.","family":"Bogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla D.","family":"Bonan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela T. S.","family":"Wyse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,2]]},"reference":[{"key":"1141_CR1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/biof.71","volume":"36","author":"KT Williams","year":"2010","unstructured":"Williams KT, Schalinske KL (2010) Homocysteine metabolism and its relation to health and disease. Biofactors 36:19\u201324","journal-title":"Biofactors"},{"key":"1141_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/ejvs.2001.1526","volume":"23","author":"M Hansrani","year":"2002","unstructured":"Hansrani M, Gillespie JI, Stansby G (2002) Homocysteine in myointimal hyperplasia. Eur J Vasc Endovasc Surg 23:3\u201310","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"1141_CR3","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1001\/jama.1993.03510220049033","volume":"270","author":"J Selhub","year":"1993","unstructured":"Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH (1993) Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270:2693\u20132698","journal-title":"JAMA"},{"key":"1141_CR4","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/ajcn\/69.3.482","volume":"69","author":"PF Jacques","year":"1999","unstructured":"Jacques PF, Rosenberg IH, Rogers G, Selhub J, Bowman BA, Gunter EW, Wright JD, Johnson CL (1999) Serum total homocysteine concentrations in adolescent and adult Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr 69:482\u2013489","journal-title":"Am J Clin Nutr"},{"key":"1141_CR5","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3949\/ccjm.71.9.729","volume":"71","author":"SR Lentz","year":"2004","unstructured":"Lentz SR, Haynes WG (2004) Homocysteine: is it a clinically important cardiovascular risk factor? Cleve Clin J Med 71:729\u2013734","journal-title":"Cleve Clin J Med"},{"key":"1141_CR6","doi-asserted-by":"crossref","unstructured":"Balogh E, Bereczky Z, Katona E, K\u0151szegi Z, Edes I, Muszbek L, Czuriga I (2011) Interaction between homocysteine and lipoprotein(a) increases the prevalence of coronary artery disease\/myocardial infarction in women: a case-control study. Thromb Res (in press)","DOI":"10.1016\/j.thromres.2011.07.001"},{"key":"1141_CR7","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","volume":"274","author":"CJ Boushey","year":"1995","unstructured":"Boushey CJ, Beresford SA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274:1049\u20131057","journal-title":"JAMA"},{"key":"1141_CR8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev.med.60.041807.123308","volume":"60","author":"BA Maron","year":"2009","unstructured":"Maron BA, Loscalzo J (2009) The treatment of hyperhomocysteinemia. Annu Rev Med 60:39\u201354","journal-title":"Annu Rev Med"},{"key":"1141_CR9","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1089\/ars.2007.1750","volume":"9","author":"L Papatheodorou","year":"2007","unstructured":"Papatheodorou L, Weiss N (2007) Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxid Redox Signal 9:1941\u20131958","journal-title":"Antioxid Redox Signal"},{"key":"1141_CR10","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ijdevneu.2011.06.004","volume":"29","author":"EB Scherer","year":"2011","unstructured":"Scherer EB, da Cunha AA, Kolling J, da Cunha MJ, Schmitz F, Sitta A, Lima DD, Delwing D, Vargas CR, Wyse AT (2011) Development of an animal model for chronic mild hyperhomocysteinemia and its response to oxidative damage. Int J Dev Neurosci 29:693\u2013699","journal-title":"Int J Dev Neurosci"},{"key":"1141_CR11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1191\/1358863x02vm428ra","volume":"7","author":"N Weiss","year":"2002","unstructured":"Weiss N, Keller C, Hoffmann U, Loscalzo J (2002) Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia. Vasc Med 7:227\u2013239","journal-title":"Vasc Med"},{"key":"1141_CR12","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1515\/CCLM.2011.084","volume":"49","author":"W Herrmann","year":"2011","unstructured":"Herrmann W, Obeid R (2011) Homocysteine: a biomarker in neurodegenerative diseases. Clin Chem Lab Med 49:435\u2013441","journal-title":"Clin Chem Lab Med"},{"key":"1141_CR13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11302-006-9003-5","volume":"2","author":"SC Robson","year":"2006","unstructured":"Robson SC, Sevigny J, Zimmermann H (2006) The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signal 2:409\u2013430","journal-title":"Purinergic Signal"},{"key":"1141_CR14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbamcr.2008.01.024","volume":"1783","author":"GG Yegutkin","year":"2008","unstructured":"Yegutkin GG (2008) Nucleotide-and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade. Biochim Biophys Acta 1783:673\u2013694","journal-title":"Biochim Biophys Acta"},{"key":"1141_CR15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1074\/jbc.M006781200","volume":"276","author":"M Solle","year":"2001","unstructured":"Solle M, Labasi J, Perregaux DG, Stam E, Petrushova N, Koller BH, Griffiths RJ, Gabel CA (2001) Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem 276:125\u2013132","journal-title":"J Biol Chem"},{"key":"1141_CR16","first-page":"1313","volume":"4","author":"GW Sullivan","year":"2003","unstructured":"Sullivan GW (2003) Adenosine A2A receptor agonists as anti-inflammatory agents. Curr Opin Investig Drugs 4:1313\u20131319","journal-title":"Curr Opin Investig Drugs"},{"key":"1141_CR17","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1021\/bi0362222","volume":"43","author":"F Bigonnesse","year":"2004","unstructured":"Bigonnesse F, L\u00e9vesque SA, Kukulski F, Lecka J, Robson SC, Fernandes MJ, S\u00e9vigny J (2004) Cloning and characterization of mouse nucleoside triphosphate diphosphohydrolase-8. Biochemistry 43:5511\u20135519","journal-title":"Biochemistry"},{"key":"1141_CR18","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0008-6363(01)00376-5","volume":"52","author":"Q Zhang","year":"2001","unstructured":"Zhang Q, Zeng X, Guo J, Wang X (2001) Effects of homocysteine on murine splenic B lymphocyte proliferation and its signal trasduction mechanism. Cardiovasc Res 52:328\u2013336","journal-title":"Cardiovasc Res"},{"key":"1141_CR19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.mad.2003.11.013","volume":"125","author":"H Dawson","year":"2004","unstructured":"Dawson H, Collins G, Pyle R, Deep-Dixit V, Taub DD (2004) The immunoregulatory effects of homocysteine and its intermediates on T-lymphocyte function. Mech Ageing Dev 125:107\u2013110","journal-title":"Mech Ageing Dev"},{"key":"1141_CR20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cbi.2006.01.004","volume":"160","author":"AE B\u00f6hmer","year":"2006","unstructured":"B\u00f6hmer AE, Pochmann D, Sarkis JJ (2006) In vitro effect of homocysteine on nucleotide hydrolysis by blood serum from adult rats. Chem Biol Interact 160:159\u2013164","journal-title":"Chem Biol Interact"},{"key":"1141_CR21","first-page":"E141","volume":"260","author":"GY Wu","year":"1991","unstructured":"Wu GY, Field CJ, Marliss EB (1991) Glutamine and glucose metabolism in rat splenocytes and mesenteric lymph node lymphocytes. Am J Physiol 260:E141\u2013E147","journal-title":"Am J Physiol"},{"key":"1141_CR22","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.lfs.2007.02.015","volume":"80","author":"FC Vuaden","year":"2007","unstructured":"Vuaden FC, de Paula Cognato G, Bonorino C, Bogo MR, Sarkis JJ, Bonan CD (2007) Lipopolysaccharide alters nucleotidase activities from lymphocytes and serum of rats. Life Sci 80:1784\u20131791","journal-title":"Life Sci"},{"key":"1141_CR23","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1016\/j.lfs.2003.11.020","volume":"74","author":"JP Oses","year":"2004","unstructured":"Oses JP, Cardoso CM, Germano RA, Kirst IB, R\u00fccker B, F\u00fcrstenau CR, Wink MR, Bonan CD, Battastini AM, Sarkis JJ (2004) Soluble NTPDase: an additional system of nucleotide hydrolysis in rat blood serum. Life Sci 74:3275\u20133284","journal-title":"Life Sci"},{"key":"1141_CR24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0003-2697(86)90640-8","volume":"157","author":"KM Chan","year":"1986","unstructured":"Chan KM, Delfert D, Junger KD (1986) A direct colorimetric assay for Ca2+-stimulated ATPase activity. Anal Biochem 157:375\u2013380","journal-title":"Anal Biochem"},{"key":"1141_CR25","first-page":"619","volume":"62","author":"GG Yegutkin","year":"1997","unstructured":"Yegutkin GG (1997) Kinectic analysis of enzymatic hydrolysis of ATP in human and rat blood serum. Biochemistry (Mosc) 62:619\u2013622","journal-title":"Biochemistry (Mosc)"},{"key":"1141_CR26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248\u2013254","journal-title":"Anal Biochem"},{"key":"1141_CR27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1124\/pr.54.4.599","volume":"54","author":"A Bree De","year":"2002","unstructured":"De Bree A, Verschuren WM, Kromhout D, Kluijtmans LA, Blom HJ (2002) Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease. Pharmacol Rev 54:599\u2013618","journal-title":"Pharmacol Rev"},{"key":"1141_CR28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000196822","volume":"27","author":"DH Benninger","year":"2009","unstructured":"Benninger DH, Herrmann FR, Georgiadis D, Kretschmer R, Sarikaya H, Schiller A, Baumgartner RW (2009) Increased prevalence of hyperhomocysteinemia in cervical artery dissection causing stroke: a case-control study. Cerebrovasc Dis 27:241\u2013246","journal-title":"Cerebrovasc Dis"},{"key":"1141_CR29","doi-asserted-by":"crossref","first-page":"17012","DOI":"10.1074\/jbc.272.27.17012","volume":"272","author":"GR Upchurch Jr","year":"1997","unstructured":"Upchurch GR Jr, Welch GN, Fabian AJ, Freedman JE, Johnson JL, Keaney JF Jr, Loscalzo J (1997) Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 272:17012\u201317017","journal-title":"J Biol Chem"},{"key":"1141_CR30","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.freeradbiomed.2003.12.001","volume":"36","author":"SJ Heydrick","year":"2004","unstructured":"Heydrick SJ, Weiss N, Thomas SR, Cap AP, Pimentel DR, Loscalzo J, Keaney JF Jr (2004) L-Homocysteine and L-homocystine stereospecifically induce endothelial nitric oxide synthase-dependent lipid peroxidation in endothelial cells. Free Radic Biol Med 36:632\u2013640","journal-title":"Free Radic Biol Med"},{"key":"1141_CR31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.exger.2003.11.005","volume":"39","author":"G Ravaglia","year":"2004","unstructured":"Ravaglia G, Forti P, Maioli F, Servadei L, Martelli M, Arnone G, Talerico T, Zoli M, Mariani E (2004) Plasma homocysteine and inflammation in elderly patients with cardiovascular disease and dementia. Exp Gerontol 39:443\u2013450","journal-title":"Exp Gerontol"},{"key":"1141_CR32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/ajcn\/82.2.335","volume":"82","author":"AM Gori","year":"2005","unstructured":"Gori AM, Corsi AM, Fedi S, Gazzini A, Sofi F, Bartali B, Bandinelli S, Gensini GF, Abbate R, Ferrucci L (2005) A proinflammatory state is associated with hyperhomocysteinemia in the elderly. Am J Clin Nutr 82:335\u2013341","journal-title":"Am J Clin Nutr"},{"key":"1141_CR33","doi-asserted-by":"crossref","first-page":"e2599","DOI":"10.1371\/journal.pone.0002599","volume":"3","author":"P Pellegatti","year":"2008","unstructured":"Pellegatti P, Raffaghello L, Bianchi G, Piccardi F, Pistoia V, Di Virgilio F (2008) Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS One 3:e2599","journal-title":"PLoS One"},{"key":"1141_CR34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tins.2008.11.003","volume":"32","author":"F Di Virgilio","year":"2009","unstructured":"Di Virgilio F, Ceruti S, Bramanti P, Abbracchio MP (2009) Purinergic signalling in inflammation of the central nervous system. Trends Neurosci 32:79\u201387","journal-title":"Trends Neurosci"},{"key":"1141_CR35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0165-6147(00)01574-1","volume":"22","author":"F Di Virgilio","year":"2001","unstructured":"Di Virgilio F, Borea PA, Illes P (2001) P2 receptors meet the immune system. Trends Pharmacol Sci 22:5\u20137","journal-title":"Trends Pharmacol Sci"},{"key":"1141_CR36","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.pharmthera.2005.04.013","volume":"112","author":"MJ Bours","year":"2006","unstructured":"Bours MJ, Swennen EL, Di Virgilio F, Cronstein BN, Dagnelie PC (2006) Adenosine 5-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther 112:358\u2013404","journal-title":"Pharmacol Ther"},{"key":"1141_CR37","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.chom.2008.08.007","volume":"4","author":"HB Yu","year":"2008","unstructured":"Yu HB, Finlay BB (2008) The caspase-1 inflammasome: a pilot of innate immune responses. Cell Host Microbe 4:198\u2013208","journal-title":"Cell Host Microbe"},{"key":"1141_CR38","first-page":"75","volume":"47","author":"M Piro","year":"2005","unstructured":"Piro M, Giubilato G, Pinnelli M, Giordano Sciacca P, Biasucci LM (2005) Endothelium and inflammation. Panminerva Med 47:75\u201380","journal-title":"Panminerva Med"},{"key":"1141_CR39","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nri1685","volume":"5","author":"M Sitkovsky","year":"2005","unstructured":"Sitkovsky M, Lukashev D (2005) Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. Nat Rev Immunol 5:712\u2013721","journal-title":"Nat Rev Immunol"},{"key":"1141_CR40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijdevneu.2004.09.001","volume":"23","author":"N Nedeljkovic","year":"2005","unstructured":"Nedeljkovic N, Banjac A, Horvat A, Stojiljkovic M, Nikezic G (2005) Developmental profile of NTPDase activity in synaptic plasma membranes isolated from rat cerebral cortex. Int J Dev Neurosci 23:45\u201351","journal-title":"Int J Dev Neurosci"},{"key":"1141_CR41","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1023\/A:1012392719601","volume":"26","author":"RA Cunha","year":"2001","unstructured":"Cunha RA (2001) Regulation of the ecto-nucleotidase pathway in rat hippocampal nerve terminals. Neurochem Res 26:979\u2013991","journal-title":"Neurochem Res"},{"key":"1141_CR42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/01.ATV.0000150651.85907.69","volume":"25","author":"NP Riksen","year":"2005","unstructured":"Riksen NP, Rongen GA, Boers GH, Blom HJ, van den Broek PH, Smits P (2005) Enhanced cellular adenosine uptake limits adenosine receptor stimulation in patients with hyperhomocysteinemia. Arterioscler Thromb Vasc Biol 25:109\u2013114","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1141_CR43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0163-7258(01)00152-8","volume":"91","author":"R Tabrizchi","year":"2001","unstructured":"Tabrizchi R, Bedi S (2001) Pharmacology of adenosine receptors in the vasculature. Pharmacol Ther 91:133\u2013147","journal-title":"Pharmacol Ther"},{"key":"1141_CR44","doi-asserted-by":"crossref","unstructured":"Deguchi H, Takeya H, Urano H, Gabazza EC, Zhou H, Suzuki K (1998) Adenosine regulates tissue factor expression on endothelial cells. Thromb Res 91:57\u201364","DOI":"10.1016\/S0049-3848(98)00045-0"},{"key":"1141_CR45","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1006\/bbrc.1994.1731","volume":"201","author":"SB Maggirwar","year":"1994","unstructured":"Maggirwar SB, Dhanraj DN, Somani SM, Ramkumar V (1994) Adenosine acts as an endogenous activator of the cellular antioxidant defense system. Biochem Biophys Res Commun 201:508\u2013515","journal-title":"Biochem Biophys Res Commun"},{"key":"1141_CR46","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF02591429","volume":"22","author":"G Marone","year":"1992","unstructured":"Marone G, Petracca R, Vigorita S, Genovese A, Casolaro V (1992) Adenosine receptors on human leukocytes. IV. Characterization of an A1\/Ri receptor. Int J Clin Lab Res 22:235\u2013242","journal-title":"Int J Clin Lab Res"},{"key":"1141_CR47","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1161\/CIRCULATIONAHA.106.649244","volume":"114","author":"Z Yang","year":"2006","unstructured":"Yang Z, Day YJ, Toufektsian MC, Xu Y, Ramos SI, Marshall MA, French BA, Linden J (2006) Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes. Circulation 114:2056\u20132064","journal-title":"Circulation"},{"key":"1141_CR48","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0002-9440(10)63698-X","volume":"163","author":"G Pinhal-Enfield","year":"2003","unstructured":"Pinhal-Enfield G, Ramanathan M, Hasko G, Vogel SN, Salzman AL, Boons GJ, Leibovich SJ (2003) An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. Am J Pathol 163:711\u2013721","journal-title":"Am J Pathol"},{"key":"1141_CR49","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.4049\/jimmunol.174.2.1073","volume":"174","author":"CM Lappas","year":"2005","unstructured":"Lappas CM, Rieger JM, Linden J (2005) A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells. J Immunol 174:1073\u20131080","journal-title":"J Immunol"},{"key":"1141_CR50","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ejphar.2010.11.003","volume":"651","author":"FC Vuaden","year":"2011","unstructured":"Vuaden FC, Savio LE, Bastos CM, Bogo MR, Bonan CD (2011) Adenosine A(2A) receptor agonist (CGS-21680) prevents endotoxin-induced effects on nucleotidase activities in mouse lymphocytes. Eur J Pharmacol 651:212\u2013217","journal-title":"Eur J Pharmacol"},{"key":"1141_CR51","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s002100000309","volume":"362","author":"H Zimmermann","year":"2000","unstructured":"Zimmermann H (2000) Extracellular metabolism of ATP and other nucleotides. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 362:299\u2013309","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"1141_CR52","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1182\/blood.V64.4.896.896","volume":"64","author":"RR Hantgan","year":"1984","unstructured":"Hantgan RR (1984) A study of the kinetics of ADP-triggered platelet shape change. Blood 64:896\u2013906","journal-title":"Blood"},{"key":"1141_CR53","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1097\/00005344-199606000-00015","volume":"27","author":"P Bodin","year":"1996","unstructured":"Bodin P, Burnstock G (1996) ATP-stimulated release of ATP by human endothelial cells. J Cardiovas Pharmacol 27:872\u2013875","journal-title":"J Cardiovas Pharmacol"},{"key":"1141_CR54","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0165-1838(00)00155-7","volume":"81","author":"GR Dubyak","year":"2000","unstructured":"Dubyak GR (2000) Purinergic signaling at immunological synapses. J Auton Nerv Syst 81:64\u201368","journal-title":"J Auton Nerv Syst"},{"key":"1141_CR55","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/sj.bjp.0703136","volume":"129","author":"G Yegutkin","year":"2000","unstructured":"Yegutkin G, Bodin P, Burnstock G (2000) Effect of shear stress on the release of soluble ecto-enzymes ATPase and 5\u00a0V-nucleotidase along with endogenous ATP from vascular endothelial cells. Br J Pharmacol 129:921\u2013926","journal-title":"Br J Pharmacol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-011-1141-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-011-1141-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-011-1141-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T10:24:34Z","timestamp":1713090274000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-011-1141-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,2]]},"references-count":55,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["1141"],"URL":"https:\/\/doi.org\/10.1007\/s11010-011-1141-6","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,2]]}}}